Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: Norway Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20064
20071
20082
20101
20121
20131
20141
20162
20173
20181
20193
20211
20221
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Unknown status4
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Norwegian University of Science and Technology3
University of Bergen3
Eli Lilly and Company2
Haukeland University Hospital2
Janssen-Cilag International NV2
Oslo University Hospital2
Ostfold Hospital Trust2
St. Olavs Hospital2
University Hospital of North Norway2
Helse Stavanger HF1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity29
Autism Spectrum Disorder1
Autistic Disorder1
Bipolar Disorder1
Epilepsy1
Intellectual Disability1
Learning Disabilities1
Neurodevelopmental Disorders1
Oppositional Defiant Disorder1
Schizophrenia1

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.